國立高雄大學圖資館 |

Language: English

Back

Biostatistics in biopharmaceutical research and development.Volume 1,Clinical trial design

Record Type:	Electronic resources : Monograph/item
Title/Author:	Biostatistics in biopharmaceutical research and development.edited by Ding-Geng Chen.
remainder title:	Clinical trial design
other author:	Chen, Ding-Geng.
Published:	Cham :Springer Nature Switzerland :2024.
Description:	xxiv, 344 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
Subject:	Clinical trialsDesign.
Online resource:	https://doi.org/10.1007/978-3-031-65948-5
ISBN:	9783031659485$q(electronic bk.)

Biostatistics in biopharmaceutical research and development.Volume 1,Clinical trial design
Biostatistics in biopharmaceutical research and development.Volume 1,Clinical trial design[electronic resource] /Clinical trial designedited by Ding-Geng Chen. - Cham :Springer Nature Switzerland :2024. - xxiv, 344 p. :ill., digital ;24 cm.

Bias and Randomization in Clinical Trials: 1980s - 2020s - 2060s -- The Markov Model for Survival Trials at 35 Years-Old -- Absolute Power Corrupts Absolutely: A Review of the Use of Unconditional Probabilities in the Planning of Clinical Trials -- Design of Clinical Trials with the Desirability of Outcome Ranking Methodology -- Benefit:Risk Assessments during Clinical Trials: A Prediction Approach Using the Desirability of Outcome Ranking (DOOR) -- The Power of Integration: How the 2-in-1 Clinical Trial Design is Changing the Future of Drug Development -- A Unified Bayesian Decision Rule-Based Approach for Bayesian Design of Clinical Trials Using Historical Data -- Group Sequential Design Under Non-proportional Hazards: Methodologies and Examples -- Multiple Testing in Group Sequential Design -- Plan per-protocol (PP) causal inference analysis addressing intercurrent events following the targeted learning roadmap -- Maximum Tolerated Imbalance Randomization: Theory and Practice -- Response-adaptive randomization designs based on optimal allocation proportion.

The Deming Conference on Applied Statistics has long been deemed an influential event in the biostatistics and biopharmaceutical profession. It provides learning experience on recent developments in statistical methodologies in biopharmaceutical applications and FDA regulations. This book honors 80 years of contributions and dedication of the Deming Conference in biostatistics, and biopharmaceutical clinical trial methodology and applications. All chapters are contributed by world-class and prominent Deming speakers, who've contributed their cutting-edge research and developments to the community. Volume 1 covers Historical Milestones in Clinical Trial Design, FDA biopharmaceutical design guidance, and emerging development in Clinical Trial Design Methodology. This book aims to booster research, education, and training in biostatistics and in biopharmaceutical research and development.

ISBN: 9783031659485$q(electronic bk.)

Standard No.: 10.1007/978-3-031-65948-5doiSubjects--Topical Terms:

490477
Clinical trials
--Design.

LC Class. No.: R853.C55

Dewey Class. No.: 615.50724

Biostatistics in biopharmaceutical research and development.Volume 1,Clinical trial design
LDR:03019nmm a2200337 a 4500 001 673570
003 DE-He213
005 20241225115231.0
006 m d
007 cr nn 008maaau
008 250422s2024 sz s 0 eng d
020 $a 9783031659485$q(electronic bk.)
020 $a 9783031659478$q(paper)
024 7 $a 10.1007/978-3-031-65948-5 $2 doi
035 $a 978-3-031-65948-5
040 $a GP $c GP
041 0 $a eng
050 4 $a R853.C55
072 7 $a PBT $2 bicssc
072 7 $a MED090000 $2 bisacsh
072 7 $a PBT $2 thema
082 0 4 $a 615.50724 $2 23
090 $a R853.C55 $b B616 2024
245 0 0 $a Biostatistics in biopharmaceutical research and development. $n Volume 1, $p Clinical trial design $h [electronic resource] / $c edited by Ding-Geng Chen.
246 3 0 $a Clinical trial design
260 $a Cham : $b Springer Nature Switzerland : $b Imprint: Springer, $c 2024.
300 $a xxiv, 344 p. : $b ill., digital ; $c 24 cm.
505 0 $a Bias and Randomization in Clinical Trials: 1980s - 2020s - 2060s -- The Markov Model for Survival Trials at 35 Years-Old -- Absolute Power Corrupts Absolutely: A Review of the Use of Unconditional Probabilities in the Planning of Clinical Trials -- Design of Clinical Trials with the Desirability of Outcome Ranking Methodology -- Benefit:Risk Assessments during Clinical Trials: A Prediction Approach Using the Desirability of Outcome Ranking (DOOR) -- The Power of Integration: How the 2-in-1 Clinical Trial Design is Changing the Future of Drug Development -- A Unified Bayesian Decision Rule-Based Approach for Bayesian Design of Clinical Trials Using Historical Data -- Group Sequential Design Under Non-proportional Hazards: Methodologies and Examples -- Multiple Testing in Group Sequential Design -- Plan per-protocol (PP) causal inference analysis addressing intercurrent events following the targeted learning roadmap -- Maximum Tolerated Imbalance Randomization: Theory and Practice -- Response-adaptive randomization designs based on optimal allocation proportion.
520 $a The Deming Conference on Applied Statistics has long been deemed an influential event in the biostatistics and biopharmaceutical profession. It provides learning experience on recent developments in statistical methodologies in biopharmaceutical applications and FDA regulations. This book honors 80 years of contributions and dedication of the Deming Conference in biostatistics, and biopharmaceutical clinical trial methodology and applications. All chapters are contributed by world-class and prominent Deming speakers, who've contributed their cutting-edge research and developments to the community. Volume 1 covers Historical Milestones in Clinical Trial Design, FDA biopharmaceutical design guidance, and emerging development in Clinical Trial Design Methodology. This book aims to booster research, education, and training in biostatistics and in biopharmaceutical research and development.
650 0 $a Clinical trials $x Design. $3 490477
650 0 $a Biometry. $3 182039
650 0 $a Biopharmaceutics. $3 224951
650 1 4 $a Biostatistics. $3 339693
650 2 4 $a Clinical Research. $3 911843
650 2 4 $a Public Health. $3 320661
650 2 4 $a Survey Methodology. $3 929641
650 2 4 $a Data Mining and Knowledge Discovery. $3 275288
700 1 $a Chen, Ding-Geng. $3 487343
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-65948-5
950 $a Medicine (SpringerNature-11650)